Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Clinician Scientist - Phase 2

McMaster University

$180,000.00

Peritoneal fibrosis and epithelial mesenchymal transition

EF 2008-09

Résumé
Epithelial mesenchymal transdifferentiation (EMT) is a ubiquitous biological process seen in development, metastatic transformation of cancer, and fibrosis. I hypothesize that EMT consists of a series of biological 'modules' and each of these 'modules' (epithelial release, migration, and invasion) is induced by different factors and involve different and redundant signaling pathways. The research outlined in this proposal will use in vivo models of fibrosis associated EMT to further our understanding of this essential biological process. In these experiments, I will induce peritoneal fibrosis using adenovirus mediated gene transfer of growth factors. This will be combined with small molecule kinase inhibitors and transgenic animals where key signal transduction elements are knocked out or inhibited. These methods will allow us to analyze in vivo signaling pathways in EMT, to understand this process in greater detail, and to develop targets for future therapeutic intervention. I see that this research will impact patients reliant on peritoneal dialysis as we develop strategies to prevent peritoneal membrane injury, but will also be important for patients with a variety of diseases marked by fibrosis - progressive renal failure, liver cirrhosis, and idiopathic pulmonary fibrosis.
Programme
CIHR Clinician Scientist - Phase 2
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
174085
Name
Margetts Peter J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Clinician Scientist
Projecttitle
Peritoneal fibrosis and epithelial mesenchymal transition
Programtype2
Salary Programs
Orgnameinp2
McMaster University
Cihramount2
$180,000
Cihrequipment2
$0
Programname2
CIHR Clinician Scientist - Phase 2
Keyworddelim
Epithelial Mesenchymal Transition; Fibrosis; Gene Transfer; Growth Factors; Peritoneal Dialysis
Abstract
Epithelial mesenchymal transdifferentiation (EMT) is a ubiquitous biological process seen in development, metastatic transformation of cancer, and fibrosis. I hypothesize that EMT consists of a series of biological 'modules' and each of these 'modules' (epithelial release, migration, and invasion) is induced by different factors and involve different and redundant signaling pathways. The research outlined in this proposal will use in vivo models of fibrosis associated EMT to further our understanding of this essential biological process. In these experiments, I will induce peritoneal fibrosis using adenovirus mediated gene transfer of growth factors. This will be combined with small molecule kinase inhibitors and transgenic animals where key signal transduction elements are knocked out or inhibited. These methods will allow us to analyze in vivo signaling pathways in EMT, to understand this process in greater detail, and to develop targets for future therapeutic intervention. I see that this research will impact patients reliant on peritoneal dialysis as we develop strategies to prevent peritoneal membrane injury, but will also be important for patients with a variety of diseases marked by fibrosis - progressive renal failure, liver cirrhosis, and idiopathic pulmonary fibrosis.
Competitiondate
200809
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Margetts, Peter J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $180,000~ $0~